The aim of this study was to inhibit influenza virus M2 protein expression by mutating the splicing signal of the M gene. Mutations were introduced into the GU dinucleotide sequence at the 5′-proximal splicing site of the M gene (corresponding to nt 52–53 of M cRNA). Transfected cells expressing mutated M viral ribonucleoproteins failed to generate M2 mRNA. Interestingly, recombinant viruses with mutations at the dinucleotide sequence were viable, albeit attenuated, in cell culture. These recombinants failed to express M2 mRNA and M2 protein. These observations demonstrated that the GU invariant dinucleotide sequence at the 5′-proximal splicing site of M gene is essential for M2 mRNA synthesis. These results also indicated that the M2 ion-channel protein is critical, but not essential, for virus replication in cell culture. This approach may provide a new way of producing attenuated influenza A virus.
AgrisC. H.,
NemeroffM. E.,
KrugR. M.1989; A block in mammalian splicing occurring after formation of large complexes containing U1, U2, U4, U5, and U6 small nuclear ribonucleoproteins. Mol Cell Biol 9:259–267
Alonso-CaplenF. V.,
KrugR. M.1991; Regulation of the extent of splicing of influenza virus NS1 mRNA: role of the rates of splicing and of the nucleocytoplasmic transport of NS1 mRNA. Mol Cell Biol 11:1092–1098
BursetM.,
SeledtsovI. A.,
SolovyevV. V.2000; Analysis of canonical and non-canonical splice sites in mammalian genomes. Nucleic Acids Res 28:4364–4375[CrossRef]
CiamporF.,
BayleyP. M.,
NermutM. V.,
HirstE. M. A.,
SugrueR. J.,
HayA. J.1992; Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment. Virology 188:14–24[CrossRef]
FodorE.,
CrowM.,
MingayL. J.,
DengT.,
SharpsJ.,
FechterP.,
BrownleeG. G.2002; A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J Virol 76:8989–9001[CrossRef]
GotoH.,
KawaokaY.1998; A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc Natl Acad Sci U S A 95:10224–10228[CrossRef]
HoffmannE.,
NeumannG.,
KawaokaY.,
HobomG.,
WebsterR. G.2000; A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97:6108–6113[CrossRef]
HoffmannE.,
StechJ.,
GuanY.,
WebsterR. G.,
PerezD. R.2001; Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146:2275–2289[CrossRef]
HugheyP. G.,
CompansR. W.,
ZebedeeS. L.,
LambR. A.1992; Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells. J Virol 66:5542–5552
HugheyP. G.,
RobertsP. C.,
HolsingerL. J.,
ZebedeeS. L.,
LambR. A.,
CompansR. W.1995; Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly. Virology 212:411–421[CrossRef]
LambR. A.,
LaiC.-J.1980; Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell 21:475–485[CrossRef]
LambR. A.,
LaiC.-J.1984; Expression of unspliced NS1 mRNA, spliced NS2 mRNA, and a spliced chimera mRNA from cloned influenza virus NS DNA in an SV40 vector. Virology 135:139–147[CrossRef]
LeahyM. B.,
PritloveD. C.,
PoonL. L. M.,
BrownleeG. G.2001; Mutagenic analysis of the 5′ arm of the influenza A virus virion RNA promoter defines the sequence requirements for endonuclease activity. J Virol 75:134–142[CrossRef]
McCrackenS.,
FongN.,
YankulovK.,
BallantyneS.,
PanG.,
GreenblattJ.,
PattersonS. D.,
WickensM.,
BentleyD. L.1997; The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385:357–361[CrossRef]
MiriamiE.,
MotroU.,
SperlingJ.,
SperlingR.2002; Conservation of an open-reading frame as an element affecting 5′ splice site selection. J Struct Biol 140:116–122[CrossRef]
NemeroffM. E.,
UtansU.,
KrämerA.,
KrugR. M.1992; Identification of cis -acting intron and exon regions in influenza virus NS1 mRNA that inhibit splicing and cause the formation of aberrantly sedimenting presplicing complexes. Mol Cell Biol 12:962–970
PlotchS. J.,
KrugR. M.1986; In vitro splicing of influenza viral NS1 mRNA and NS1– β -globin chimeras: possible mechanisms for the control of viral mRNA splicing. Proc Natl Acad Sci U S A 83:5444–5448[CrossRef]
PoonL. L. M.,
PritloveD. C.,
FodorE.,
BrownleeG. G.1999; Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template. J Virol 73:3473–3476
PoonL. L. M.,
FodorE.,
BrownleeG. G.2000; Polyuridylated mRNA synthesized by a recombinant influenza virus is defective in nuclear export. J Virol 74:418–427[CrossRef]
RobertsP. C.,
LambR. A.,
CompansR. W.1998; The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology 240:127–137[CrossRef]
ShihS.-R.,
KrugR. M.1996; Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells. EMBO J 15:5415–5427
ShihS.-R.,
NemeroffM. E.,
KrugR. M.1995; The choice of alternative 5′ splice sites in influenza virus M1 mRNA is regulated by the viral polymerase complex. Proc Natl Acad Sci U S A 92:6324–6328[CrossRef]
SugrueR. J.,
BahadurG.,
ZambonM. C.,
Hall-SmithM.,
DouglasA. R.,
HayA. J.1990; Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J 9:3469–3476
TakedaM.,
PekoszA.,
ShuckK.,
PintoL. H.,
LambR. A.2002; Influenza A virus M2 ion channel activity is essential for efficient replication in tissue culture. J Virol 76:1391–1399[CrossRef]
TakeuchiK.,
LambR. A.1994; Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J Virol 68:911–919
ValcárcelJ.,
FortesP.,
OrtínJ.1993; Splicing of influenza virus matrix protein mRNA expressed from a simian virus 40 recombinant. J Gen Virol 74:1317–1326[CrossRef]
WatanabeT.,
WatanabeS.,
ItoH.,
KidaH.,
KawaokaY.2001; Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity. J Virol 75:5656–5662[CrossRef]
WatanabeT.,
WatanabeS.,
KidaH.,
KawaokaY.2002; Influenza A virus with defective M2 ion channel activity as a live vaccine. Virology 299:266–270[CrossRef]
WeberS.,
AebiM.1988; In vitro splicing of mRNA precursors: 5′ cleavage site can be predicted from the interaction between the 5′ splice region and the 5′ terminus of U1 snRNA. Nucleic Acids Res 16:471–486[CrossRef]